$AMGN
AMGEN Inc.
- NASDAQ
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
PRICE
$217.2 β²0.124%
Extented Hours
VOLUME
3,081,160
DAY RANGE
214.48 - 218.48
52 WEEK
214.48 - 286.63
Join Discuss about AMGN with like-minded investors
@stevengo #StockTraders.NET
recentlyCHWY MA ZM FUTU BILI BIDU Short TTD RBLX LLY DLTR AMGN UPS
118 Replies 11 π 12 π₯
@DarkPoolAlgo #Dark Pool Charts
recentlyU.S. futures are holding steady, only moderately lower from yesterdayβs closing all-time highs for the major averages as investors brace for the FOMC meeting, with results expected tomorrow afternoon. Bitcoin prices surging to highs, up over 4% around $63,400 in another broad spike for crypto assets; Ethereum +3.25% at $4,450. House Speaker Pelosi is planning to go ahead with plans to vote this week on President Bidenβs two bills even though Democratic moderates are echoing Senator Manchinβs complaints that they donβt know full cost & economic impact. In corporate news, JNJ, TEVA, ENDP and ABBV win the first case for pharmaceutical companies in the four-year litigation over the drugs in a $50B opioid litigation case. In commodity prices, gold holds below $1,800, oil is little changed around $84 per barrel and Wheat hit $8.00 a bushel Monday, highest levels since 2012 as world reserves declined following extreme weather. The Aussie dollar drops and the curve bull steepens after the RBA scraps its April 2024 yield target and signals openness to earlier rate hikes. Tesla $TSLA falls over 4%, is falling off a record high close of $1,208.59 β follows tweet from CEO Musk overnight saying there has been no contract signed yet with Hertz and that the Hertz deal has zero effect on Teslaβs economic. Wall Streetβs main indexes notched record closing highs again on Monday, adding to the big totals in October as Tesla $TSLA shares surged and the energy sector gained on rising oil prices while investors looked ahead to a major Federal Reserve meeting later in the week. The Dow Jones Industrial Average briefly eclipsed 36,000 points for the first time before slipping just below. Along with the barrage of earnings again this week, the Federal Reserve is expected to approve plans to scale back its $120 billion monthly bond-buying program on Wednesday. The small-cap Russell 2000 index was a standout, rising 2.7% for its biggest daily percentage gain since late August. Economic data was mixed as the ISM U.S. manufacturing activity slowed in October, with all industries reporting record-long lead times. In Asian markets, The Nikkei Index slipped -0.43% to 29,520, the Shanghai Index dropped -1.1% to 3,505, and the Hang Seng Index fell -0.22% to 25,099. In Europe, the German DAX is up +0.4% at 15,875, while the FTSE 100 declines around -0.6% below 7,250. Events Calendar for Today Β· 7:45 AM ET ICSC Weekly Retail Sales Β· 8:55 AM ET Johnson/Redbook Weekly Sales Earnings Calendar: Β· Earnings Before the Open: AME, APO, ARCB, AVNS, BBGI, BCC, BHC, BLD, BLMN, CEIX, CLW, CMI, COP, CRSR, CTLT, DD, EL, EPD, ESPR, ETN, EXLS, EXPD, EXTR, GNRC, GPN, HEES, HEP, HSC, HSIC, IART, IDXX, INCY, IPGP, IT, KKR, LCII, LDOS, LEA, LGIH, LPX, MIME, MLM, MMP, MPC, MPLX, MYGN, NRZ, NXST, NYMT, OMCL, PFE, PINC, RL, ROK, SABR, SAGE, SEE, TMX, TNC, UAA, VAL, WEC, WLK, XHR, XYL ZBRA Β· Earnings After the Close: ACT, AFG, AIZ, AKAM AMGN, ANDE, ATVI, AWK, AYX, BFAM, BGFV, BKH, BRY, BXC, CASA, CDK, CERS, CHK, COUR, CRK, CSLT, CZR, DCO, DCPH, DEI, DENN, DOX, DRRX, DVN, EGHT, EIX, ENLC, EXAS, EXEL, FMC, FNF, FRSH, GAIN, GNW, GPOR, HALO, HCC, HLF, HRB, HURN, INFI, INSP, KAI, KAMN, KAR, LPI, LSCC, LSI, LYFT, MANT, MDLZ, MG, MGNX, MOD, MRCY, MTCH, NP, NSA, OKE, OVV, PAA, PAGP, PAYC, PKI, PRO, PRTS, PRU, RAMP, RARE, RCKY, RM, RRR, SGRY, SKY, SRC, STE, TCS, TMUS, TVTY, UIS, UNM, VECO, VOYA, VRSK, WTTR, WU, ZG Other Key Events: Β· China Caixin Services PMI for October Β· Wolfe Research Wealth Symposium, 11/2-11/3 $virtual Β· Senator Manchin says he is prepared to support a Build Back Better plan that combats inflation, is fiscally responsible, and will create jobs. The plan the House is finalizing meets those tests-it is fully paid for, will reduce the deficit, and brings down costs for health care, child care, elder care, and housing
120 Replies 6 π 13 π₯
@Benlax #droscrew
recentlyAlso got rid of PEP AMGN half AAPL and half JPM. First buys MTCH NTDOY TCEHY GFL TWLO in order of size
133 Replies 9 π 8 π₯
@DarkPoolAlgo #Dark Pool Charts
recentlyWednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over Chinaβs gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for Julyβ¦est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for Julyβ¦est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesarβs Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Dennyβs ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers β residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the companyβs decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the companyβs $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) β BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philipsβ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death β Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of coβs long-term debt was $7.1 bln
126 Replies 8 π 9 π₯
@DarkPoolAlgo #Dark Pool Charts
recentlyThursday, July 8, 2021 Futures Up/Down % Last Dow -494.00 1.43% 34,074 S&P 500 -60.25 1.40% 4,289 Nasdaq -196.50 1.33% 14,606 Stocks slide around the globe, as the S&P 500 and Nasdaq Composite tumble following fresh all-time highs on Wednesday. A delayed reaction? Stocks were little changed late afternoon following the release of the FOMC Minutes from its prior meeting, where Fed officials saw a tightening of monetary policy potentially happening sooner than expected as the economy recovers from the pandemic, but no move to taper asset purchases seems imminent. At the same time, worries about the economic recovery continue to weigh as the Covid-19 delta variant has spread rapidly in countries with lagging vaccination rates, as the WHO urged caution on worldwide reopenings. In Asian markets, The Nikkei Index dropped -248 points to 28,118, the Shanghai Index slid -28 points to 3,525 and the Hang Seng Index tumbled 2.9% or 800 points to settle at 27,153. In Europe, markets are broadly lower as the German DAX drops over 270 points to 15,420, while the FTSE 100 slides around 2% to hold just above the 7,000 level. European equities are deep in the red with most indexes printing fresh lows for the week. Eurostoxx 50 drops as much as 1.9%, while all Stoxx 600 sectors are in the red, with miners, retail and banks performing the worst. Market Closing Prices Yesterday The S&P 500 Index gained 14.59 points, or 0.34%, to 4,358.13 The Dow Jones Industrial Average rose 104.42 points, or 0.30%, to 34,681.79 The Nasdaq Composite edged higher 1.42 points, or 0.01%, to 14,665.06 The Russell 2000 Index declined -21.66 points, or 0.95% to 2,252.85 Events Calendar for Today 8:30 AM ET Weekly Jobless Claimsβ¦est. 350K 8:30 AM EST Continuing Claimsβ¦est. 3.335M 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Weekly DOE Inventory Data 3:00 PM ET Consumer Credit for Mayβ¦est. $18.4B Earnings Calendar: Earnings Before the Open: $HELE Earnings After the Close: $ACCD, $DCT, $KSHB, $LEVI, $PSMT Other Key Events: China Producer Price Index and Consumer Price Index for June Macro Up/Down Last Nymex -0.80 71.40 Brent -0.66 72.77 Gold 7.10 1,810.75 EUR/USD 0.0036 1.1826 JPY/USD -0.82 109.84 10-Year Note -0.066 1.255% Sector News Breakdown Consumer GAN ($GAN) rises after saying sees Q2 revs between $34-$35M, beating the consensus of $23.98M; positive Adj. EBITDA to be $3-$7M as higher than expected revenue more than offset strategic investments in talent and technology Overstock ($OSTK) initiated with a Buy and $150 tgt at Needham WD-40 ($WDFC) Q3 EPS $1.52 vs. est. $1.15; Q3 sales rose 39% to $136.4M vs. est. $108.33M; sees FY sales $475m-$490m vs. rest. $461.85M; do not expect to see sales growth of current magnitude over long-term Tesla ($TSLA) introduced a new, lower-priced version of the Model Y to the China market; the Standard Range Model Y starts at 276,000 yuan ($42,600) after government subsidies and incentives; Tesla began taking orders for the vehicle on Thursday. Didi ($DIDI) shares on track for a 4th straight decline after IPO last week, extending the losses suffered as Asian stocks listed in New York also drop following a day of declines for tech companies in Hong Kong. Stellantis ($STLA) slips after saying adjusted operating income margins in 1H are expected to exceed previously communicated FY margin guidance range of 5.5% to 7.5%; said expects negative industrial free cash flows in 1H Energy, Industrials and Materials American Petroleum Institute ($API) showed a draw of 7.98M barrels of oil for the latest week; gasoline inventories showed a draw of 2.74M barrels, distillate inventories show a build of 1.09M barrels and Cushing inventories show a build of 152K barrels. Freeport McMoRan ($FCX) downgraded to Underweight from Equal Weight at Barclays Rio Tinto ($RIO) and South Korean steelmaker POSCO agreed to jointly develop technologies to transition to a low-carbon emission steel value chain. Maxar Technologies ($MAXR) contracts for WorldView Legion satellite constellation capacity through an expanded agreement with a key international defense and intelligence customer (multi-year, $35M contract) Sonoco ($SON) updates $115 million project horizon progress; announces intentions to close 70,000 tons/year of capacity at Hartsville mill complex; investment to convert Hartsville, S.C., corrugated medium machine to urb scheduled to be completed in q2 of 2022 The Federal Aviation Administration issued an emergency directive requiring main rotor inspections for ~400 Textron ($TXT) Bell helicopters after Canadian and U.S. investigators discovered a possible flaw while probing a fatal crash last week. Financials Cryptocurrency-exposed stocks like $RIOT, $MARA, $MSTR, looking sharply lower in premarket trading with Bitcoin sinking back below $33,000 per token, down over 5%, with Ethereum down over 7% to slip below $2,200 Charles Schwab ($SCHW) downgraded to Neutral from Conviction Buy at Goldman Sachs Pzena Investment Management Inc. ($PZN) preliminary total AUM as of June 30, 2021 was $53.1 bln Healthcare Amgen ($AMGN) said the U.S. FDA has accepted a Biologics License Application ($BLA) and granted Priority Review for Tezepelumab in the treatment of asthma; Tezepelumab is being developed by Amgen in collaboration with AstraZeneca ($AZN) Ideaya Biosciences ($IDYA)64M share Secondary priced at $17.25 SeaSpine Holdings ($SPNE) said the U.S. FDA has granted a 510k clearance for the companyβs 7D Percutaneous Spine Module for minimally invasive surgery Technology, Media & Telecom Alphabet Incβs ($GOOGL) slides as thirty-seven U.S. states and district attorneys general sued Google on Wednesday, alleging the search giant bought off competitors; also alleged that the co was using restrictive contracts to unlawfully maintain a monopoly for its app store on Android phones Tessco Technologies ($TESS) shares jump over 30% after the company said Wednesday evening it expects 2022 1Q total revenue of $105M, 9% higher than a year earlier
101 Replies 10 π 12 π₯
@viking #StockTraders.NET
recentlyAfter Market Close: AAT, ACCO, ACGL, AMD, AMGN, APAM, ARAY, ATEN, ATNI, ATRC, AWRE, BXP, BYD, CALX, CASH, CB, CHE, CHRW, CIEL3.BR, COF, CS.CA, CSGP, CYBE, EGP, EHC, EIX, ENPH, EQR, ESS, FCNCA, FCPT, FEYE, FFIC, FFIV, FIBK, FM.CA, FN.CA, FTI, GOOGL, HA, HAFC, HIW, HOPE, HRZN, HVT, IEX, ILMN, JNPR, LAIX, LBC, LBRT, LDL, MANH, MATX, MDLZ, MRC, MRG.UN.CA, MSFT, MXIM, NAVI, NCR, NOV, OKE, OLN, OMAB, PFG, PINS, PPD, PSB, QCRH, QTS, RNST, ROIC, RRD, RXN, SBUX, SES.CA, SPFI, SYK, TENB, TER, TFII.CA, TRMK, TRMT, TX, TXN, UDR, USNA, V, VBTX, WSBC, YUMC - Source TradeTheNews.com
102 Replies 13 π 13 π₯
@jcarlgohn #StockTraders.NET
recentlyCovered $AMGN 242.53 to 241.45; about +1
133 Replies 12 π 12 π₯
@jcarlgohn #StockTraders.NET
recentlyHave my ss on $AMGN from $242.53 from yesterday's close; showing a +2 point proft for me on level 2 right now; will see how tape is at the open; would like to see it flush to yesterday's low of 235+/- for a +7 win
117 Replies 13 π 8 π₯
@jcarlgohn #StockTraders.NET
recentlyLooking to go short $AMGN right before the close
65 Replies 12 π 15 π₯
Key Metrics
Market Cap
115.91 B
Beta
0
Avg. Volume
2.21 M
Shares Outstanding
534.33 M
Yield
3.68%
Public Float
0
Next Earnings Date
2023-08-03
Next Dividend Date
Company Information
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
CEO: Robert Bradway
Website: www.amgen.com
HQ: 1 Amgen Center Dr Thousand Oaks, 91320-1799 California
Related News